Panacea Biopharmatec is the sister company of Panacea Biochem devoted to the physical craft of the dosage form. The active pharmaceutical ingredient is only the beginning: someone must teach it to flow, to bind, to compress, to carry a coat, to release on cue. That craft — formulation, granulation, tablet pressing, film coating, excipient science — is our house's whole subject.
Between the pure API in its drum and the tablet in a patient's hand stands a chain of unit operations, each with its own physics and its own failure modes. Panacea Biopharmatec's work is that entire chain — no step of it outsourced to luck.
A formulation is a negotiation between the API and everything that must surround it. Solubility, polymorph, particle size, stability — the molecule sets the constraints, and the formulation answers them. The first question is never "which excipient" but "what does this API refuse to tolerate".
If a blend flows freely and mixes evenly, direct compression is the honest route: fewest steps, least stress on the API. When it does not, the powder is first engineered — wet granulation with a binder liquid and drying, or dry granulation by roller compaction when moisture and heat are unwelcome. The powder chooses the route.
Inside a rotary press, punches and dies turn a metered volume of powder into a compact in a fraction of a second. Tooling geometry, compression force and dwell time set the tablet's strength — and the trade-off is real: harder tablets resist chipping but may disintegrate too slowly. Friability, hardness and disintegration are tuned together, never separately.
A polymer film tens of microns thick, sprayed onto tumbling cores. Cosmetic coats give gloss, colour and identity; functional coats mask taste, shield against moisture and light, or — as enteric barriers — carry the tablet untouched through the stomach to release in the intestine. We keep the two categories honest: a coat that only decorates is never sold as protection.
Fillers for bulk, binders for strength, disintegrants for break-up, lubricants so the press lets go, glidants so the powder flows. Excipients are called inactive, but nothing that decides whether a tablet exists at all is truly inert. Their grades, particle sizes and interactions are engineering parameters, not afterthoughts.
Two questions close the loop. Does every tablet carry the same dose — content uniformity, fought against segregation at every transfer step? And does the tablet release its API at the rate the therapy assumes — dissolution, the rehearsal of what the body will ask? A batch answers both, or it does not ship.
Every tablet is a small powder-compaction experiment run at industrial tempo. Air must escape the die before the punches close; particles must deform and bond in milliseconds; the compact must survive ejection without capping or lamination. Get the balance wrong and the press tells you immediately — in chipped edges, in split crowns, in weights that drift. Get it right and the machine settles into the oldest rhythm in solid dose manufacturing: fill, compress, eject. The full lineage — Brockedon, Korsch, Fette, Manesty, Wurster — is told on The Craft page.
Panacea Biochem (panaceabiochem.co.uk) is the molecular sister: peptides, lyophilization and formulation research — the LyoLevit levitated freeze-drying platform and the peptide-preservation line. Panacea Biopharmatec is the manufacturing-technology sister: everything the API meets after it exists — blending, granulation, compression, coating, release. One designs the substance; the other teaches the substance to become a dosage form. Both answer to the same founder, biochemist and AAC designer Bogdan Dicoias, and to the same rule: state precisely what is known, and nothing more.
Technology house · no products offered for sale on this site"The molecule is the argument; the tablet is the verdict. Formulation is where a brilliant API learns manners — how to flow, how to hold together, and how to let go at exactly the right moment."
Bogdan Dicoias — Biochemist · AAC Designer · founder of Panacea Biopharmatec
The sister company of Panacea Biochem devoted to API manufacturing technology: the formulation science and unit operations that turn an active pharmaceutical ingredient into a real, manufacturable dosage form.
Panacea Biochem works on molecules — peptides, lyophilization, formulation research. Panacea Biopharmatec works on the physical craft of the dosage form: powder behaviour, compression, coating and release.
The powder decides. Well-behaved blends go straight to the press; difficult blends are granulated first — wet, or dry by roller compaction when solvent and heat are unwelcome.
Cosmetic coats give gloss and identity; functional coats mask taste, protect the API, or form an enteric barrier that postpones release until the intestine. More answers on the Questions page.
Recent developments in the field — refreshed 2026-07-27 by Panacea Bio Chem.
No publication indexed in PubMed in the last 30 days for "API manufacturing" OR "tablet press" — the most recent in the field, refreshed weekly.
The Panacea Technology Universe
Proprietary Panacea Bio Chem Ltd technologies, invented by Bogdan Dicoias — what each one does, and why it leads its class.
Lyoprester®The only dual-chamber cartridge that is autoreconstitution-enabled, vacuum-sealed and argon-fillback.lyoprester.com ↗
P-EARLs™Panacea-Engineered Aseptic Reconstitution Liquid(s) — each tuned to the peptide it wakes.p-earls.com ↗
Peptourbillon™The layered peptide formulation architecture — single- or multi-layer, never a blend.peptourbillon.com ↗
RF Tunnel™The RF-formed central channel through the cake.rftunnel.com ↗
TgShift™Raises the cake’s glass-transition temperature with RF — instead of chilling below it.tgshift.com ↗
Cryolapse™Cryogenic pressure collapse — and the machine that pushes plungers and crimps.cryolapse.com ↗
LyoLevit™The cake levitates and spins in high orbit — driven by ultrasound and RF.lyolevit.com ↗
Lyochrysalis™The integrated chamber housing the whole drying stack.lyochrysalis.com ↗
S3Pulse™The control brain for every piece of Panacea hardware.s3pulse.com ↗
Liquiprester™The single-liquid cartridge engineered so multiple peptide APIs coexist in one shared vehicle.liquiprester.com ↗
Syntheseract™Continuous-flow peptide synthesis in a special, very fast and economical way.syntheseract.com ↗
CFSPPS™Continuous-flow solid-phase peptide synthesis, written as its own category.cfspps.com ↗
OxyDeplete™Degassing plus no-headspace doctrine — the oxygen-starved seal.oxydeplete.com ↗
ArgonLock™The final inert-atmosphere lock under argon.argonlock.com ↗
RedoxVault™Separation, not merely suppression — redox isolation in lipid micro-reservoirs.redoxvault.com ↗
PleniDose™The shared filling gantry — one machine filling both the dual-chamber Lyoprester and the liquid Liquiprester.plenidose.com ↗
IncreSure™The dose-metrology layer — verified API per pen increment.incresure.com ↗
ElimiVoid™Front-void elimination without touching the metered dose.elimivoid.com ↗
Cryoviscous™The characterised cold, high-viscosity, low-mobility conditioning state.cryoviscous.com ↗
Vana Machine™Vacuum Assisted Needle Accessory — vacuum conditioning and plunger-locking for the cartridge.
EZnject™The disposable auto-injector pen built around the Lyoprester.panaceaeznject.com ↗
Dicoias ΨThe computed-chemistry advisory — every substance reduced to a vector across physical, electronic and formulation space.dcppsi.com ↗
SealoPrester™Aseptic Cartridge Closure System — Seal o’ Precision + Sterility.sealoprester.com ↗
Peptidic LiquidThe peptide formulation in solution — the active plus its buffers, cryoprotectants, lyoprotectants and scaffolders.peptidicliquid.com ↗